00:12 , Jul 6, 2016 |  BC Extra  |  Financial News

BioGeneration raises EUR 25 million for third fund

BioGeneration Ventures announced a EUR 25 million ($27.8 million) first close for the firm's third life sciences fund. BioGeneration Capital Fund III is targeting a final close of EUR 50 million ($55.6 million). LPs include...
07:00 , Apr 25, 2011 |  BC Week In Review  |  Company News

Avantium Holding B.V. high throughput screening, supply/service news

Avantium spun out its screening services and contract research business into newco Crystallics B.V. Avantium said the spin-out will allow it to focus on its YXY green chemistry technology. Avantium does not have a stake...
08:00 , Feb 16, 2009 |  BC Week In Review  |  Company News

Acacia Pharma board of directors update

Acacia Pharma Ltd. , Cambridge, U.K.   Business: Gastrointestinal, Endocrine   Appointed: Ian Kent as non-executive chairman, currently chairman of Intercytex Group plc , Argenta Discovery Ltd. and Avantium Holdings B.V.  ...
07:00 , May 19, 2008 |  BioCentury  |  Finance

Ebb & Flow

Making good on plans to expand its footprint in Asia, MPM Capital made a $20 million investment in Hyderabad CRO Sai Avantium last week. The company's primary focus is on providing chemistry services to biotech...
07:00 , Aug 13, 2007 |  BC Week In Review  |  Company News

Avantium management update

Avantium Technologies B.V. , Amsterdam, the Netherlands   Business: Supply/Service   Hired: Sylvia Hinds as VP of business development, formerly director of business development at PPD Inc.  ...
08:00 , Jan 22, 2007 |  BC Week In Review  |  Company News

Avantium International B.V. management update

Avantium International B.V. , Amsterdam, the Netherlands   Business: Chemistry   Hired: Frank Roerink as CFO, formerly director of M&A at Unilever N.V.; he replaces Rene de Witte, who departed in May 2006  ...
07:00 , Sep 11, 2006 |  BC Week In Review  |  Company News

Avantium International B.V., sanofi-aventis deal

SAN will use Avantium's Crystal16 technology for crystallization research at all SAN's R&D centers. Crystal16 is a platform for performing parallel crystallization experiments. Avantium International B.V. , Amsterdam, the Netherlands   sanofi-aventis Group (Euronext:SAN; SNY),...
08:00 , Jan 26, 2004 |  BC Week In Review  |  Company News

Avantium International BV, Chiral Quest deal

Avantium will add Chiral's chiral ligand catalysts to its existing catalyst library for use with its high throughput screening and simulation technology. Avantium International BV , Amsterdam, the Netherlands   Chiral Quest Inc. , State...
07:00 , May 13, 2002 |  BioCentury  |  Finance

Ebb & Flow

A little more than two years after its hyped-up creation, a piece of the Franco-American venture ValiGen N.V. filed for bankruptcy protection last week, and the financial outlook for its other ventures remain uncertain. ValiGen...
07:00 , May 6, 2002 |  BioCentury  |  Strategy

Mature start-ups

Mature start-ups Company Type Date Raised (M) Description Ovation NRDO 5/2 $150.0 In-licenses under-marketed drugs for niche markets Kalypsys Spin-out 4/2 $43.0 Spun out of Novartis Research Foundation's Genomics Institute in 2001 to validate therapeutic...